In a world where numerous industries are reevaluating the transformative potential of artificial intelligence (AI), the pharmaceutical sector is already experiencing revolutionary changes in drug discovery. Companies like GSK and
Drug Research2- Page
39Articles
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), a stem cell-derived exosome-based drug delivery platform developer, is currently seeking new investors to enable the company to trade as a going concern following its
A study found that people who were prescribed a weight loss injection are at an increased risk of developing a condition in the eye which can cause blindness. Researchers found
Experts have predicted that weight-loss medicines will see a boom in popularity, now that the first generic versions are available at lower prices than the original drugs. Media-dubbed “skinny jabs”,
Nestle will sell dietary supplements that counter the effects of weight loss drugs to “Ozempic Face”. The company announced that it would launch products to “complement” weight loss treatments. These
Eli Lilly’s Alzheimer’s treatment donanemab is getting closer to US approval after an independent panel of scientific experts determined that the benefits outweighed the risk. The US Food and Drug
Doctors said that weight-loss drugs are a powerful weapon in the fight against cancer. They have “enormous” potential to shrink tumours and prevent new cases. Blockbuster injections such as Wegovy
According to doctors, the world’s first personalised cancer vaccine for melanoma reduces the risk that patients will die or have the disease return. According to the 2020 statistics from World
AstraZeneca is the largest drug manufacturer in Britain. It has set a bold goal to achieve $80bn ($63bn) by 2030 through treatments for cancer and rare diseases. Pascal Soriot, the
Novo Nordisk wants to increase the use of its blockbuster treatments. It is testing their weight loss drugs to see if they reduce alcohol consumption and treat alcoholic hepatitis. The
Sir John Bell, one of Britain’s leading life sciences leaders, warned of an imminent exodus of pharmaceutical companies from London, calling the City “a bad place to raise funds”. Sir
In the US, a new gene therapy that treats a rare genetic disorder that attacks the nervous system central of young children is priced at $4.25mn. This makes it the
Most people prefer to take a pill rather than inject themselves with medication when they are sick. This simple fact helped Novo-Nordisk, (stock ticker:NOVO), to become the third-most valuable holding
The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its
AstraZeneca will spend £650m to build a new factory for vaccines in Liverpool, and upgrade research labs at Cambridge. This comes almost a full year after the chief executive of
The shares of US biotech Viking Therapeutics have more than doubled since trial results for its weight-loss drug beat existing treatments from Novo Nordisk & Eli Lilly. In a mid-stage
